Home › Funds › Cormorant Asset Management, LP › ASND

Cormorant Asset Management, LP position in ASND

ASCENDIS PHARMA A/S · Health Care

Cormorant Asset Management, LP reported holding 50,000 shares of ASND (ASCENDIS PHARMA A/S) in its Q2 2026 13F filing — a position valued at US$13.3M, representing 0.68% of its reported portfolio and ranking #32 among its reported holdings. Cormorant Asset Management, LP has disclosed ASND holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)50.00K sh
Reported value held$13.34M
Portfolio Weight0.68%
First reportedQ4 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Cormorant Asset Management, LP's ASND position evolved

Cormorant Asset Management, LP first disclosed a stake in ASND in Q4 2025 at 100,000 shares (US$21.3M). The position peaked in Q1 2026 at 95,000 shares, worth US$21.7M. Across 3 filings, Cormorant Asset Management, LP increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 50,000 shares valued at US$13.3M — a reduction of -45,000 shares quarter over quarter.. Notable position changes include a 47% trim in Q2 2026 (shares fell 15% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 100.00K $21.32M New
Q1 2026 95.00K $21.73M Reduce
Q2 2026 50.00K $13.34M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ASND and 13F data

ASND (ASCENDIS PHARMA A/S) is a Health Care company. 43 other funds we track also report a position in ASND — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$2.74B), T. Rowe Price Investment Management, Inc. (US$1.80B), Avoro Capital Advisors LLC (US$1.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ASND

All ASND fund holders →

FAQ

How long has Cormorant Asset Management, LP held ASND?

Cormorant Asset Management, LP has disclosed ASND holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Cormorant Asset Management, LP's current position in ASND?

As of Q2 2026, Cormorant Asset Management, LP holds 50.00K shares of ASND (ASCENDIS PHARMA A/S), valued at $13.34M, representing 0.68% of its reported portfolio and ranking #32.

Has Cormorant Asset Management, LP been buying or selling ASND?

In the latest 13F filing (Q2 2026), Cormorant Asset Management, LP reduced its position in ASND. The position peaked in Q1 2026 at 95.00K shares.

Which other funds hold ASND?

Other major institutional holders of ASND include RA CAPITAL MANAGEMENT, L.P., T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.